| Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer CJ Whatcott, CH Diep, P Jiang, A Watanabe, J LoBello, C Sima, ... Clinical cancer research 21 (15), 3561-3568, 2015 | 687 | 2015 |
| Progesterone action in breast, uterine, and ovarian cancers CH Diep, AR Daniel, LJ Mauro, TP Knutson, CA Lange Journal of molecular endocrinology 54 (2), R31-R53, 2015 | 240 | 2015 |
| Chemistry-first approach for nomination of personalized treatment in lung cancer EA McMillan, MJ Ryu, CH Diep, S Mendiratta, JR Clemenceau, ... Cell 173 (4), 864-878. e29, 2018 | 134 | 2018 |
| Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells CH Diep, KM Zucker, G Hostetter, A Watanabe, C Hu, RM Munoz, ... PloS one 7 (3), e32783, 2012 | 109 | 2012 |
| Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells C Diep, N Charles, C Blake Gilks, S Kalloger, P Argenta, CA Lange Cell Cycle 12 (9), 1433-1449, 2013 | 101 | 2013 |
| Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and … CH Diep, H Ahrendt, CA Lange Steroids 114, 48-58, 2016 | 90 | 2016 |
| Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cells CH Diep, RM Munoz, A Choudhary, DD Von Hoff, H Han Clinical cancer research 17 (9), 2744-2756, 2011 | 90 | 2011 |
| Phosphorylated progesterone receptor isoforms mediate opposing stem cell and proliferative breast cancer cell fates TH Truong, AR Dwyer, CH Diep, H Hu, KM Hagen, CA Lange Endocrinology 160 (2), 430-446, 2019 | 64 | 2019 |
| Progesterone receptor–cyclin D1 complexes induce cell cycle–dependent transcriptional programs in breast cancer cells GE Dressing, TP Knutson, MJ Schiewer, AR Daniel, CR Hagan, CH Diep, ... Molecular Endocrinology 28 (4), 442-457, 2014 | 55 | 2014 |
| Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer C Perez Kerkvliet, AR Dwyer, CH Diep, RH Oakley, C Liddle, ... Breast Cancer Research 22, 1-23, 2020 | 51 | 2020 |
| Active FOXO1 is a key determinant of isoform-specific progesterone receptor transactivation and senescence programming CH Diep, TP Knutson, CA Lange Molecular Cancer Research 14 (2), 141-162, 2016 | 32 | 2016 |
| Progesterone receptors promote quiescence and ovarian cancer cell phenotypes via DREAM in p53-mutant fallopian tube models LJ Mauro, MI Seibel, CH Diep, A Spartz, C Perez Kerkvliet, H Singhal, ... The Journal of Clinical Endocrinology & Metabolism 106 (7), 1929-1955, 2021 | 15 | 2021 |
| Progesterone receptor signaling promotes cancer associated fibroblast mediated tumorigenicity in ER+ breast cancer CH Diep, A Spartz, TH Truong, AR Dwyer, D El-Ashry, CA Lange Endocrinology 165 (9), bqae092, 2024 | 4 | 2024 |
| Navigating a plethora of progesterone receptors: Comments on the safety/risk of progesterone supplementation in women with a history of breast cancer or at high-risk for … CH Diep, LJ Mauro, CA Lange Steroids 200, 109329, 2023 | 1 | 2023 |
| Methods and kits to predict therapeutic outcome of BTK inhibitors H Han, D Von Hoff, CH Diep, H Yin US Patent 9,371,567, 2016 | 1 | 2016 |
| Inhibition of XIAP expression sensitizes pancreatic cancer cells to gemcitabine C Diep, D Von Hoff, H Han Molecular Cancer Therapeutics 6 (11_Supplement), A190-A190, 2007 | 1 | 2007 |
| Progesterone receptor mediated crosstalk between cancer associated fibroblasts (CAFs) and ER+/PR+ breast cancer cells through CAF-secreted FGF2 AK Spartz, CH Diep, CA Lange, D El-Ashry Cancer Research 83 (7_Supplement), 3084-3084, 2023 | | 2023 |
| Progesterone receptors promote quiescence & ovarian cancer cell phenotypes via modulation of DREAM in p53-mutant fallopian tube models LJ Mauro, MI Seibel, CH Diep, A Spartz, CP Kerkvliet, H Singhal, ... Cancer Research 81 (13_Supplement), 744-744, 2021 | | 2021 |
| Convergence of cancer associated fibroblasts (CAFs) and progesterone receptor (PR) signaling in ER+ luminal breast cancer A Spartz, C Diep, B Troness, CA Lange, D El-Ashry Cancer Research 81 (13_Supplement), 2513-2513, 2021 | | 2021 |
| 4543 Glucocorticoid Receptors are essential effectors of TGFβ signaling in Triple Negative Breast Cancer CJP Kerkvliet, AR Dwyer, C Diep, R Oakley, C Liddle, CA Lange Journal of Clinical and Translational Science 4 (s1), 7-8, 2020 | | 2020 |